A 32-year-old woman presents with a 3-day history of fever, myalgia, and hypotension. She has a diffuse erythematous rash on her trunk and extremities. She had a surgical wound infection 5 days ago from which Staphylococcus aureus was isolated. Which of the following is NOT a recognized mechanism by which this organism causes toxic shock syndrome?

Explanation

## Staphylococcus aureus Toxic Shock Syndrome (TSS): Mechanisms ### Correct Answer: Exotoxin-Mediated Direct Invasion and Destruction of Intestinal Epithelium **Key Point:** TSS is caused by *superantigen-mediated* systemic inflammation and cytokine storm, NOT by direct bacterial invasion or epithelial destruction. The pathophysiology is immunological, not invasive. ### Recognized Mechanisms of S. aureus TSS | Mechanism | Toxin | Pathophysiology | Clinical Outcome | |---|---|---|---| | **Superantigen activation** | TSST-1, Enterotoxins A, B, C | Bypasses MHC-TCR interaction; activates 5–30% of T cells (vs. 0.01% in normal response) | Massive IL-2, TNF-α, IFN-γ release; cytokine storm | | **Polyclonal T-cell expansion** | TSST-1 | Cross-links MHC class II on APCs to TCR Vβ regions | Uncontrolled proliferation; systemic inflammation | | **Capillary leak** | Superantigens via TNF-α, IL-1, IL-6 | Endothelial dysfunction; loss of fluid into interstitium | Hypotension, shock, multi-organ failure | | **Rash production** | IL-2, TNF-α | Inflammatory infiltrate in dermis; increased vascular permeability | Diffuse erythematous rash (often desquamating) | **High-Yield:** TSS is a **toxin-mediated systemic inflammatory response**, not an invasive infection. The bacteria may be localized to a wound or vagina; the toxins diffuse systemically and trigger immune dysregulation. ### Why Direct Invasion/Epithelial Destruction Is NOT a Mechanism of TSS 1. **TSS occurs with localized infection:** The bacteria are often confined to a surgical wound, tampon site, or skin lesion. Systemic symptoms arise from *toxin diffusion*, not bacterial dissemination. 2. **Superantigens work remotely:** TSST-1 and enterotoxins are secreted proteins that act on distant immune cells (T cells and APCs) in the bloodstream and lymphoid tissue. 3. **Histology shows minimal bacterial invasion:** Biopsies of TSS rash show inflammatory infiltrate and endothelial damage, but NOT bacterial invasion or epithelial necrosis. 4. **Antibiotics targeting bacterial growth do not reverse TSS:** Once superantigens are released, the inflammatory cascade continues even if bacterial growth is stopped. This is why TSS can progress despite appropriate antibiotics. **Clinical Pearl:** Patients with S. aureus TSS often have a *localized* source (surgical wound, necrotizing fasciitis, pneumonia) but *systemic* manifestations (fever, rash, shock, multi-organ failure). The disconnect between local infection and systemic illness is a hallmark of superantigen-mediated disease. ### Authentic Mechanisms (Options A, B, C) **Option A — TSST-1 as superantigen:** ✓ Correct. TSST-1 is the most common toxin in menstrual TSS and post-surgical TSS. It directly cross-links MHC class II to TCR Vβ, causing polyclonal T-cell activation. **Option B — Enterotoxin B as superantigen:** ✓ Correct. Enterotoxins A, B, and C are also superantigens. Enterotoxin B is frequently associated with food-borne illness but can also cause TSS in the context of invasive infection. **Option C — LPS as endotoxin:** ✓ Correct. Although S. aureus is Gram-positive (and LPS is typically associated with Gram-negative bacteria), S. aureus does have lipoteichoic acid (LTA) in its cell wall, which acts similarly to LPS as a pathogen-associated molecular pattern (PAMP). However, the *primary* mechanism of S. aureus TSS is superantigen-mediated, not endotoxin-mediated.